Restoration of impaired p38 activation by insulin in insulin resistant skeletal muscle cells treated with thiazolidinediones

Molecular and Cellular Biochemistry

Volumn 260, Issue 1, 2004, Pages 55-64

  Kumar, Naresh ^a   Dey, Chinmoy S ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Glucose uptake; Insulin resistance; P38; Skeletal muscle; Thiazolidinediones

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PIOGLITAZONE; ROSIGLITAZONE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN SENSITIVITY; MOUSE; MUSCLE CELL; NONHUMAN; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE;

ANIMALS; BLOTTING, WESTERN; CELL LINE; DEOXYGLUCOSE; DRUG RESISTANCE; ENZYME ACTIVATION; ENZYME INHIBITORS; IMIDAZOLES; INSULIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SKELETAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; THIAZOLIDINEDIONES;

EID: 4344573243     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000026054.60072.48     Document Type: Article

References (41)

1. Lewis TS, Shapiro PS, Ahn NG: Signal transduction through MAP kinase cascades. Adv Cancer Res 74: 49-139, 1998
2. Ludwig S, Hoffmeyer A, Goebeler M, Kilian K, Hafner H, Neufeld B, Han J, Rapp UR: The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J Biol Chem 273: 1917-1922, 1998
3. Ishrath A, Kumar N, Dey CS: Differential activation of ERK and JNK by arsenite in mouse muscle cells. Comp Biochem Physiol 132C: 375-384, 2002
4. Recio JA, Merlino G: Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene 21: 1000-1008, 2002
5. Zentrich E, Han SY, Pessoa-Brandao L, Butterfield L, Heasley LE: Collaboration of JNKs and ERKs in nerve growth factor regulation of the neurofilament light chain promoter in PC12 cells. J Biol Chem 277: 4110-4118, 2002
6. i2 in vivo mimics insulin activation of c-Jun N-terminal kinase and p38 kinase. J Biol Chem 273: 16487-16493, 1998
7. Somwar R, Perreault M, Kapur S, Taha C, Sweenet G, Ramlal T, Kim DY, Keen J, Cote CH, Klip A, Marette A: Activation of p38 mitogen-activated protein kinase α and β by insulin and contraction in rat skeletal muscle. Diabetes 49: 1794-1800, 2000
8. Farese RV: Insulin-sensitive phospholipid signaling systems and glucose transport. Update II. Exp Biol Med 226: 283-295, 2001
9. Cefalu WT: Insulin resistance: Cellular and clinical concepts. Exp Biol Med 226: 13-26, 2001
10. Somwar R, Kim DY, Sweeney G, uang C, Niu W, Lador C, Ramlal T, Klip A: GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: Potential activation of GLUT4 via p38 mitogen-activated protein kinase. Biochem J 359: 639-649, 2001
11. Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T, Klip A: The antihyperglycemic drug α-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation. Diabetes 50: 1464-1471, 2001
12. Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A: An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 274: 10071-10078, 1999
13. Clancy BM, Harrison SA, Buxton JM, Czech MP: Protein synthesis inhibitors activate glucose transport without increasing plasma membrane glucose transporters in 3T3-L1 adipocytes. J Biol Chem 266: 10122-10130, 1991
14. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ: Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 105: 311-320, 2000
15. 307. J Biol Chem 275: 9047-9054, 2000
16. Huang C, Somwar R, Patel N, Niu W, Torok D, Klip A: Sustained exposure of L6 myotubes to high glucose and insulin decreases insulin-stimulated GLUT4 translocation but upregulates GLUT4 actiivty. Diabetes 51: 2090-2098, 2002
17. Olefsky JM: Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists. J Clin Invest 106: 467-472, 2000
18. Arakawa K, Ishihara T, Aoto M, Inamasu M, Saito A, Ikezawa K: Actions of novel antidiabetic thiazolidinediones, T-174, in animal models of non-insulin-dependent diabetes mellitus (NIDDM) and in cultured muscle cells. Br J Pharmacol 125: 429-436, 1998
19. El-Kebbi IM, Roser S, Pollet RJ: Regulation of glucose transport by pioglitazone in cultured muscle cells. Metabolism 43: 953-958, 1994
20. Ciaraldi TP, Huber-Knudsen K, Hickman M, Olefsky JM: Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents. Metabolism 44: 976-982, 1995
21. Kumar N, Dey CS: Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells. Biochem Pharmacol 65: 249-257, 2003
22. Tsiani E, Ramlal T, Leiter LA, Klip A, Fantus IG: Stimulation of glucose uptake and increased plasma membrane content of glucose transporters in L6 skeletal muscle cells by suffonylureas gliclazide and glyburide. Endocrinology 136: 2505-2512, 1995
23. Ricort JM, Tanti JF, Obberghen EV, Le Marchand-Brustel Y: Alterations in insulin signaling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes. Diabetologia 38: 1148-1156, 1995
24. Chang PY, Le Marchand-Brustel Y, Cheatham LA, Moller DE: Insulin stimulation of mitogen-activated protein kinase, p90rsk, and p70 S6 kinase in skeletal muscle of normal and insulin-resistant mice. Implications for the regulation of glycogen synthase. J Biol Chem 270: 29928-29935, 1995
25. Engelman JA, Berg AH, Lewis RY, Lisanti MP, Scherer PE: Tumor necrosis factor α-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Mol Endocrinol 14: 1557-1569, 2000
26. Jain RG, Meredith MJ, Pekala PH: Tumor necrosis factor-α mediated activation of signal transduction cascades and transcription factors in 3T3-L1 adipocytes. Adv Enzyme Regul 38: 333-347, 1998
27. Lennon AM, Ramauge M, Dessouroux A, Pierre M: MAP kinase cascades are activated in astrocytes and preadipocytes by dPGJ2 and the thiazolidinedione ciglitazone through PPAR γ independent mechanisms involving ROS. J Biol Chem 277: 29681-29685, 2002
28. Napoli R, Gibson L, Hirshman MF, Boppart MD, Dufresne SD, Horton ES, Goodyear LJ: Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Diabetes 47: 1549-1554, 1998
29. Kayali AG, Austin DA, Webster NJG. Stimulation of MAPK cascades by insulin and osmotic shock. Diabetes 49: 1783-1793, 2000
30. Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onishi Y, Ono H, Funaki M, Inukai K, Fukushima Y, Kikuchi M, Oka Y, Asano T: MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. J Biol Chem 276: 19800-19806, 2001
31. Moyers JS, Bilan PJ, Reynet C, Kahn CR: Overexpression of rad inhibits glucose uptake in cultured muscle and fat cells. J Biol Chem 271: 23111-23116, 1996
32. 12 satellite cells: Effect of differentiation and fusion. Biochim Biophys Acta 1355: 167-176, 1997
33. Sarabia V, Lam L, Burdett E, Leiter LA, Klip A. Glucose transport in human skeletal muscle cells in culture: stimulation by insulin and metformin. J Clin Invest 90: 1386-1395, 1992
34. Lawson MA, Purslow PP: Differentiation of myoblasts in serum-free media: effects of modified media are cell line-specific. Cells Tissues Organs 167: 130-137, 2000
35. Pinset C, Gros F, Whalen R: Proliferation and differentiation of a myogenic line in synthetic media. CR Sean Acad Sci 295: 727-732, 1982
36. Conejo R, Lorenzo M: Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts. J Cell Physiol 187: 96-108, 2001
37. Goto S, Miyazaki K, Funabiki T, Yasumitsu H: Serum-free culture conditions for the analysis of secretory proteinases during myogenic differentiation of mouse C2C12 myoblasts. Anal Biochem 272: 135-142, 1999
38. Cabrero À, Alegret M, Sánchez RM, Adzet T, Laguna JC, Manuel V: Down-regulation of uncoupling protein-3 and -2 by thiazolidinediones in C2C12 myotubes. FEBS Lett 484: 37-42, 2000
39. Nagase I, Yoshida S, Canas X, I Yukiko, Kimura K, Yoshida T, Saito M: Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes. FEBS Lett 461
40. Yonemitsu S, Nishimura H, Shintani M, Inoue R, Yamamoto Y, Masuzaki H, Ogawa Y, Hosoda K, Inoue G, Hayashi T, Nakao K: Troglitazone induces GLUT 4 4 translocation in L6 myotubes. Diabetes 50: 1093-1101, 2001
41. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ: Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420-7426, 1995